Anicom Holdings, Inc. (8715) AI Stock Analysis

• Market Cap: ¥45.23B
• Dividend Yield: 1.29%
• Average Volume (3M): 546.51K
• Price to Earnings (P/E): 14.6
• Beta (1Y): 0.67
• Revenue Growth: 7.94%
• EPS Growth: 26.40%
• Country: JP
• Employees: 933
• Sector: Financial
• Sector Strength: 86
• Industry: Insurance - Property & Casualty
• EPS (TTM): 5.34
• Shares Outstanding: 74,939,160
• 10 Day Avg. Volume: 500,630
• 30 Day Avg. Volume: 546,510
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Anicom Holdings, Inc. shows strong fundamental stability with solid revenue growth and a robust balance sheet. However, technical indicators are bearish, implying potential downside risk. The low P/E ratio suggests undervaluation, but the stock's recent price performance is a concern. Improvements in cash flow management and reversal of bearish trends could enhance the stock's attractiveness.

Anicom Holdings, Inc. Business Overview & Revenue Model

Company Description

Anicom Holdings, Inc. (8715) is a Japanese company primarily engaged in the provision of pet insurance services. The company operates within the insurance sector, with its core offerings focused on providing comprehensive coverage for pets, including dogs and cats. Anicom Holdings aims to ensure pet owners can manage their pets' healthcare needs effectively, providing peace of mind through its insurance solutions.

How the Company Makes Money

Anicom Holdings, Inc. generates revenue mainly through the sale of pet insurance policies. Customers pay regular premiums for insurance coverage, which constitutes the primary revenue stream for the company. The company's earnings are influenced by the number of active policies, policy premiums, and claims ratios. Anicom may engage in partnerships with veterinary clinics and pet-related businesses to expand its customer base and enhance service offerings, although specific partnerships are not detailed. Additionally, prudent investment of insurance premiums into financial markets could contribute to income, although the specifics of such investments are not disclosed.

Anicom Holdings, Inc. Financial Statement Overview

Summary

Anicom Holdings, Inc. demonstrates strong revenue growth and operational efficiency, supported by a solid balance sheet with low leverage. However, the decline in free cash flow growth indicates potential constraints in cash generation or increased capital expenditures. Overall, the company is financially stable with growth potential, but improvements in cash flow management could enhance performance.

Income Statement

Anicom Holdings, Inc. shows strong revenue growth with a 6.3% increase in TTM compared to the previous annual report. The gross profit margin is exceptionally high, consistently near 100%, indicating effective cost management or revenue model. Net profit margin in the TTM is around 5.1%, showing profitability but with room for improvement. The EBIT margin improved significantly in the TTM, suggesting enhanced operational efficiency. However, EBITDA margin decreased, indicating rising non-operating expenses or depreciation.

Balance Sheet

The company maintains a robust balance sheet with a low debt-to-equity ratio of 0.36, implying conservative leverage use. The equity ratio stands at 40.2%, reflecting strong equity financing relative to assets. Return on equity is stable at 11.6% in the TTM, indicating effective use of shareholders' capital. This solid balance sheet suggests financial stability and lower financial risk.

Cash Flow

The free cash flow experienced a decline of 64.8% in TTM, which could be concerning for long-term investments. However, the operating cash flow to net income ratio of 0.59 indicates moderate cash generation efficiency. The free cash flow to net income ratio also suggests that while cash flow generation is positive, there is potential for improvement in converting earnings to cash.

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
60.33B	56.41B	52.81B	47.87B	41.35B
	Gross Profit
60.43B	56.41B	52.81B	47.87B	41.35B
	EBIT
11.00M	2.55B	1.93B	1.47B	1.40B
	EBITDA
5.17B	4.53B	4.07B	3.35B	2.93B
	Net Income Common Stockholders
2.73B	2.28B	2.11B	1.59B	1.52B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
23.88B	30.84B	29.64B	31.68B	24.43B
	Total Assets
66.36B	61.41B	58.63B	55.46B	45.60B
	Total Debt
5.00B	5.00B	5.00B	5.00B	34.00M
	Net Debt
-18.88B	-25.84B	-24.64B	-26.68B	-24.39B
	Total Liabilities
36.21B	5.00B	31.32B	29.74B	22.27B
	Stockholders Equity
29.90B	28.18B	27.32B	25.71B	23.32B
Cash Flow		Free Cash Flow
4.83B	3.57B	3.24B	3.07B	3.06B
	Operating Cash Flow
5.67B	4.42B	4.46B	4.23B	4.25B
	Investing Cash Flow
-11.13B	-4.07B	-5.49B	-2.13B	-10.26B
	Financing Cash Flow
-1.34B	-212.00M	-112.00M	5.15B	-99.00M

Anicom Holdings, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 630.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8715, the sentiment is Positive. The current price of 630 is above the 20-day moving average (MA) of 554.40, above the 50-day MA of 532.28, and above the 200-day MA of 613.22, indicating a bullish trend. The MACD of 24.80 indicates Negative momentum. The RSI at 77.15 is Negative, neither overbought nor oversold. The STOCH value of 92.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8715.

Anicom Holdings, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8766	73 Outperform	$10.78T	10.30	22.63%	2.66%	14.87%	74.60%
8630	72 Outperform	$4.64T	9.77	17.07%	2.63%	11.37%	27.90%
8725	67 Neutral	¥5.17T	7.17	17.38%	2.93%	-1.15%	104.17%
8715	66 Neutral	¥45.23B	14.55		1.29%	7.94%	26.40%
8795	64 Neutral	$1.55T	10.39	11.57%	2.44%	7.47%	58.38%
8750	64 Neutral	¥3.82T	8.48	13.11%	3.03%	2.99%	81.04%
Sector *	64 Neutral	$12.54B	9.79	7.92%	16985.69%	12.58%	-6.07%

Anicom Holdings, Inc. Corporate Events

Anicom Holdings Reports Growth in Pet Insurance and Advances in Regenerative Medicine

Anicom Holdings, Inc. has released its monthly management parameters for February 2025, highlighting its progress in the pet insurance sector and new business initiatives. The company reported an increase in net premiums written and the number of policies in force compared to the previous year. Additionally, Anicom is advancing its regenerative medicine business through the Research and Development Partnership for Animal Regenerative Medicine (PARM), which aims to standardize cell therapy services for domestic animals. The company is also promoting its BioInsurTech initiatives, focusing on preventing injuries and illnesses using big data.

Anicom Holdings Announces Treasury Share Cancellation

Anicom Holdings, Inc. has announced a decision to cancel a portion of its treasury shares, specifically 6,370,000 shares, which represents 7.83% of the total issued shares prior to cancellation. This move, set to take effect on March 31, 2025, will reduce the total number of issued shares to 74,939,160, potentially impacting shareholder value and market perception.

Anicom Holdings Completes Share Repurchase and Plans Future Capital Optimization

Anicom Holdings has completed a share repurchase as part of its capital policy, following a resolution from its Board of Directors. With a stable financial position and surplus capital, the company plans to continue optimizing capital efficiency and may consider further share repurchases in future fiscal years, while maintaining compliance with solvency regulations.

Anicom Holdings Reports Progress in Pet Insurance and New Initiatives

Anicom Holdings reported its management parameters for December 2024, detailing its progress in the pet insurance and new business sectors. The company recorded growth in net premiums written, an increase in the number of policies in force, and maintained a stable renewal rate. It also reported advancements in its regenerative medicine and BioInsurTech initiatives, with an increase in the number of PARM hospitals and patents held. These developments underscore Anicom’s strategic shift towards a prevention-oriented business model, aiming to enhance its market position and offer innovative healthcare solutions for pets.